|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑
! h- O) J8 Y6 k6 Y& }
) \ p- \ Q& D- K5 s' B今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况2 g) H3 v& V. @4 M
. C: f$ f5 D5 c5 W0 c9 T0 d+ f3 u% tLB2. TransRadial versus transfemoral Arterial access for CErebral angiography, d% {0 D, @( H) s8 E" P
Wei Ni, Huashan Hospital, Fudan University, Shanghai, China9 w# X6 H a, u
, O+ P a0 i, Z! NLB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial6 x$ o, B4 r- S. V
Xuening Zhang, West China Hospital, Sichuan University, Chendu, China5 U. j. x( O# h/ T
0 {+ o9 r4 {& {% I# }, C, vLB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
3 r: w4 X8 E c, p* s* o/ ?4 bMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China
4 h8 [: Q8 H! M* O4 t& h
; t# s" ]+ X) ]8 @LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail
7 [2 o! n* K7 }Xianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China% d2 c4 T) X" i% @: J T; l2 y
9 V9 ?8 o8 v( i0 qLB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours4 ~! e2 G( r( u7 y
Min Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China2 c9 ]" m/ u! U- B) ^: x0 z) i
2 j# D) j6 }# E' n/ x2 I$ @LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial7 T0 S) j5 v0 t# A9 K$ F4 k3 Y
Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China) v k& ?2 n+ z/ [) g" u" u: l
8 r/ P' [$ q4 l7 s% m* ]' Z fLB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial
. f9 O$ d& o% D- A; \+ @Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China6 c# [% y1 S7 U' e6 c0 V6 }
) w& g% O6 P+ g5 m8 ELB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial/ i8 G. G# h7 c5 {/ C/ C( ^1 x
Yarong Ding, Beijing Tiantan Hospital, Beijing, China
5 F# p; e; {* X* y; ?- }
5 ?$ ?5 h) Y& x5 K祝贺以上单位！
* X6 [- D# [0 P4 ^2 D |
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
